These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Survey confirms fears about licensing of genetic tests. Schissel A; Merz JF; Cho MK Nature; 1999 Nov; 402(6758):118. PubMed ID: 10646997 [No Abstract] [Full Text] [Related]
23. Patenting of genetic material: are the benefits to society being realized? Willison DJ; MacLeod SM CMAJ; 2002 Aug; 167(3):259-62. PubMed ID: 12186174 [No Abstract] [Full Text] [Related]
24. Diagnostic method patents and harms to follow-on innovation. Harv Law Rev; 2013 Mar; 126(5):1370-91. PubMed ID: 25330558 [No Abstract] [Full Text] [Related]
26. Legal developments and practical implications of gene patenting on targeted drug discovery and development. Klein RD Clin Pharmacol Ther; 2010 Jun; 87(6):633-5. PubMed ID: 20485317 [TBL] [Abstract][Full Text] [Related]
27. The impact of patenting on DNA diagnostic practice. Matthijs G; Hodgson S Clin Med (Lond); 2008 Feb; 8(1):58-60. PubMed ID: 18335671 [TBL] [Abstract][Full Text] [Related]
28. U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes. Levenson D Am J Med Genet A; 2013 Sep; 161A(9):ix-x. PubMed ID: 23946205 [No Abstract] [Full Text] [Related]
29. The continuing saga of patents and non-invasive prenatal testing. Hawkins N; Nicol D; Chandrasekharan S; Cook-Deegan R Prenat Diagn; 2019 May; 39(6):441-447. PubMed ID: 30900262 [TBL] [Abstract][Full Text] [Related]
30. Continental drift? Do European clinical genetic testing laboratories have a patent problem? Liddicoat J; Liddell K; McCarthy AH; Hogarth S; Aboy M; Nicol D; Patton S; Hopkins MM Eur J Hum Genet; 2019 Jul; 27(7):997-1007. PubMed ID: 30846855 [TBL] [Abstract][Full Text] [Related]
31. From Bilski back to Benson: preemption, inventing around, and the case of genetic diagnostics. Dreyfuss R; Evans JP Stanford Law Rev; 2011 Jun; 63(6):1349-76. PubMed ID: 21774194 [TBL] [Abstract][Full Text] [Related]
32. Genetic testing, ethical concerns, and the role of patent law. Caulfield TA; Gold ER Clin Genet; 2000 May; 57(5):370-5. PubMed ID: 10852371 [TBL] [Abstract][Full Text] [Related]
33. [Legal aspects of genetic testing for diagnostic purposes in France]. Zordan C; Dorian V; Jameau L; Goizet C Med Sci (Paris); 2018 Nov; 34 Hors série n°2():13-15. PubMed ID: 30418138 [No Abstract] [Full Text] [Related]
34. The dangers of diagnostic monopolies. Cook-Deegan R; Chandrasekharan S; Angrist M Nature; 2009 Mar; 458(7237):405-6. PubMed ID: 19325608 [No Abstract] [Full Text] [Related]
35. Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia. Berthels N; Matthijs G; Van Overwalle G Eur J Hum Genet; 2011 Nov; 19(11):1114-21. PubMed ID: 21811306 [TBL] [Abstract][Full Text] [Related]
36. Patents on breast cancer genes are illegal and stymie research, say scientists. Lenzer J BMJ; 2009 Nov; 339():b4899. PubMed ID: 19920010 [No Abstract] [Full Text] [Related]
37. Gene patents and the standard of care. Gold R; Caulfield TA; Ray PN CMAJ; 2002 Aug; 167(3):256-7. PubMed ID: 12186172 [No Abstract] [Full Text] [Related]
38. HHS panel examines effects of patents, licenses on genetic testing. Lavine G Am J Health Syst Pharm; 2009 Jan; 66(2):114, 116. PubMed ID: 19139472 [No Abstract] [Full Text] [Related]
39. Patent pools and standard setting in diagnostic genetics. Ebersole TJ; Guthrie MC; Goldstein JA Nat Biotechnol; 2005 Aug; 23(8):937-8. PubMed ID: 16082359 [No Abstract] [Full Text] [Related]
40. Research exemption/experimental use in the European Union: patents do not block the progress of science. Jaenichen HR; Pitz J Cold Spring Harb Perspect Med; 2014 Nov; 5(2):a020941. PubMed ID: 25377145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]